Comment Re:Figures (Score 5, Insightful) 138
"There is no safety or cost reason to prefer this over normal analog protein vaccines. Only advantage MRNA has is reduced up front capex."
Nice attempt at shaping the discussion to flow down the limited paths you prefer. In reality world the gigantic advantages of having straightforward yearly influenza vaccines be mRNA-based is that (1) after enough experience it would become possible to reformulate the vaccine midseason if the dominant flu strain changes (2) if a 1918 Kansas Flu boils up out of a giant pig farm somewhere it will be possible to create an mRNA vaccine for it and get it into distribution rapidly.